Search details
1.
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
Lab Invest
; 102(9): 957-965, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35488033
2.
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.
Haematologica
; 106(8): 2066-2075, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-32646889
3.
ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity.
Haematologica
; 104(7): 1407-1416, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30630977
4.
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
Haematologica
; 104(7): 1396-1406, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30630978
5.
Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?
Am J Hematol
; 98(10): E269-E271, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37449465
6.
Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia.
Haematologica
; 106(3): 886-890, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-32499245
7.
Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study.
Leukemia
; 38(1): 21-30, 2024 01.
Article
in English
| MEDLINE | ID: mdl-38001170
8.
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease.
Leukemia
; 36(12): 2793-2801, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35933523
9.
A novel class of ZNF384 aberrations in acute leukemia.
Blood Adv
; 5(21): 4393-4397, 2021 11 09.
Article
in English
| MEDLINE | ID: mdl-34529760
10.
Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia.
Cancers (Basel)
; 13(10)2021 May 12.
Article
in English
| MEDLINE | ID: mdl-34066083
11.
Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1.
Hemasphere
; 4(6): e489, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-33204999
Results
1 -
11
de 11
1
Next >
>>